Sanofi Avantis Chief Executive Christopher Viehbacher presents the 2009 full year results Wednesday Feb.10, 2010 in Paris. Sanofi-Aventis reported a 10 percent increase in fourth quarter net profit Wednesday as strong sales of its swine flu vaccine drove full year earnings above expectations. France's largest drug maker said net profit rose to Euro 1.8 billion ($2.5 billion) in the three months ending Dec. 31 from $1.63 billion a year earlier.
(AP Photo/Francois Mori)